Insider Transactions in Q2 2025 at Rockwell Medical, Inc. (RMTI)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2025
|
Joan Lau Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+30.65%
|
-
|
|
May 20
2025
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.84%
|
-
|
|
May 20
2025
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.15%
|
-
|
|
May 20
2025
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.96%
|
-
|
|
May 20
2025
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.58%
|
-
|
|
May 20
2025
|
Timothy Chole SVP and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+39.35%
|
-
|
|
May 20
2025
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.03%
|
-
|
|
May 20
2025
|
Mark Strobeck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
220,000
+38.96%
|
-
|
|
May 20
2025
|
Megan C. Timmins EVP, CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+36.99%
|
-
|
|
May 20
2025
|
Jesse Neri SVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+43.33%
|
-
|
|
Apr 11
2025
|
Irrevocable Larson Family Investment Trust > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,500
+0.07%
|
$30,500
$1.08 P/Share
|
|
Apr 10
2025
|
Irrevocable Larson Family Investment Trust > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
57,000
+0.1%
|
$57,000
$1.06 P/Share
|
|
Apr 01
2025
|
Jesse Neri SVP and CFO |
SELL
Open market or private sale
|
Direct |
886
-2.87%
|
$886
$1.1 P/Share
|
|
Apr 01
2025
|
Mark Strobeck President and CEO |
SELL
Open market or private sale
|
Direct |
6,926
-5.26%
|
$6,926
$1.08 P/Share
|
|
Apr 01
2025
|
Timothy Chole SVP and CCO |
SELL
Open market or private sale
|
Direct |
2,868
-5.86%
|
$2,868
$1.08 P/Share
|